USANA Reports Flat Q1 Revenue of $250M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 05 2026
0mins
Reports Q1 revenue $250M, flat year-over-year. "Our first quarter 2026 results reflect USANA's continued evolution from a single-channel direct sales business to a diversified, omnichannel health and wellness enterprise," said Kevin Guest, Chairman and Chief Executive Officer. "Our omnichannel platform is intended to provide multiple growth engines, and early progress across our three segments reinforces confidence that our strategy will deliver sustained incremental value over time. The Core Nutritional business delivered solid sequential improvement during the quarter, driven by growth in total active customers in China in addition to continued focus on accelerating our new product launch initiatives. Meanwhile, Hiya established the operational foundation for a meaningfully stronger second half of the year and Rise Wellness generated triple-digit growth as Protein Pop hit Costco shelves nationwide."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy USNA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on USNA
Wall Street analysts forecast USNA stock price to rise
1 Analyst Rating
0 Buy
1 Hold
0 Sell
Hold
Current: 18.840
Low
39.00
Averages
39.00
High
39.00
Current: 18.840
Low
39.00
Averages
39.00
High
39.00
No data
About USNA
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures nutritional supplements, functional foods and personal care products. Its segments include Core nutritional and Hiya direct-to-consumer. The Core nutritional segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the core nutritional channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal care and Skincare, and All other. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
USANA Earns Spot on 2026 USA TODAY Top Workplaces List
- Employee Culture Recognition: USANA Health Sciences has earned a spot on the 2026 USA TODAY Top Workplaces list, indicating its standout performance among 40,500 participating organizations and reflecting its commitment to a people-first culture and employee engagement.
- Benefits and Support: The company provides free onsite gym and healthcare amenities along with competitive health insurance plans, demonstrating its commitment to employee health and well-being, which enhances employee satisfaction and retention.
- Educational Support Policy: USANA also supports continuing education through tuition reimbursement, further enhancing employees' career development opportunities and improving the overall talent quality within the company.
- Feedback-Driven Recognition: The award is based on anonymous employee feedback collected through Energage surveys, emphasizing the credibility of the company's leadership and the alignment of employees with the corporate culture, thereby increasing the company's appeal to job seekers and customers.
See More
USANA Health Sciences Q1 2026 Earnings Call Insights
- Sales Growth Highlight: USANA's core nutritional business achieved net sales of $204 million in Q1 2026, reflecting a 7% sequential increase driven by active customer growth, particularly in the Chinese market, which strengthens the company's competitive foundation in the health product sector.
- Hiya Performance: Hiya generated $32 million in net sales in the first quarter with 186,000 active subscribers, and despite facing disruptions in the Meta advertising environment, management anticipates stronger performance in the second half of 2026, indicating its market potential and customer appeal.
- Rise Wellness Market Performance: Rise Wellness delivered $14 million in net sales for Q1, with growth primarily attributed to the national launch of Protein Pop Plus at Costco, showcasing effective retail execution strategies that support future sales growth for the company.
- Full-Year Outlook: USANA reaffirmed its full-year 2026 net sales guidance of $925 million to $1 billion, while projecting Hiya's sales between $140 million and $155 million, demonstrating the company's confidence in future growth and emphasis on technology modernization investments.
See More
USANA Health Sciences Q1 Earnings Exceed Expectations
- Earnings Beat: USANA Health Sciences reported a Q1 non-GAAP EPS of $0.61, exceeding expectations by $0.17, indicating a strong rebound in profitability that boosts investor confidence.
- Revenue Growth: The company achieved $250 million in revenue for Q1, a 0.2% year-over-year increase, surpassing market expectations by $9.01 million, demonstrating stable sales performance in a competitive market.
- Fiscal Year 2026 Outlook: USANA reiterated its fiscal year 2026 outlook, projecting core nutritional business net sales between $720 million and $765 million, reflecting confidence in future growth driven by product innovation and omnichannel strategies.
- Profitability Forecast: The company expects net earnings between $20 million and $27 million for FY 2026, with diluted EPS ranging from $1.11 to $1.45, and adjusted diluted EPS between $1.95 and $2.29, indicating ongoing improvements in profitability.
See More
The Power of Smiling in Leadership
- Impact of Smiling: Kevin Guest, CEO of USANA Health Sciences, emphasizes that smiling is not just superficial; it conveys care and trust, quickly reducing stress and improving interpersonal interactions, thereby enhancing workplace atmosphere.
- Essence of Leadership: Guest highlights through personal experiences and research that a smile can change people's responses, stressing the importance of caring for others and remembering names in one's career, as these small actions can have a profound impact.
- Importance of Relationships: He underscores that building strong relationships is central to both leadership and personal fulfillment, where clear goals and a strong 'why' can guide actions, fostering teamwork and execution.
- Charity and Social Responsibility: By selling his book,
See More
USANA Launches Glow™, Its First Skin Supplement
- Product Innovation: USANA has launched Glow™, a skincare supplement designed to support skin health at the cellular level, marking a strategic shift from traditional topical products to internal supplements, which is expected to attract consumers focused on inner beauty.
- Ingredient Advantage: Glow™ features clinically supported ingredients like Damasty®, along with astaxanthin from red algae and grape seed extract, aimed at enhancing skin moisture barriers and resisting environmental stress, thereby increasing the product's market competitiveness.
- Clinical Validation: Clinical trials involving 162 women aged 18 to 65 demonstrated significant improvements in skin appearance with Glow™, and consumer feedback indicates its effectiveness in enhancing skin radiance and even tone, further bolstering the brand's credibility.
- Market Outlook: As consumers increasingly prioritize internal skin health, the launch of Glow™ not only meets market demand but also opens new growth opportunities for USANA in the skincare sector, which is expected to drive future sales growth.
See More
USANA Launches Glow™, Its First Skin Supplement
- Product Innovation: USANA has launched Glow™, its first skin supplement designed to support skin health at the cellular level, marking a strategic shift from traditional topical solutions to internal supplements, catering to consumer demand for holistic beauty.
- Ingredient Advantage: Glow™ features clinically studied ingredients like Damasty®, along with rose extract and bioactive melon superoxide dismutase, which help enhance skin radiance and evenness while boosting the skin's resilience against environmental stressors, showcasing significant antioxidant effects.
- Clinically Proven Results: In clinical trials involving 162 women, Glow™ demonstrated a 26% increase in skin radiance after two months and a 40% increase after three months, with 100% of participants reporting improved skin radiance within two months, underscoring the product's efficacy.
- Market Potential: As consumers increasingly prioritize internal beauty, the introduction of Glow™ not only expands USANA's product line but also opens new growth opportunities in the competitive skincare market, expected to drive sales growth and enhance brand loyalty.
See More
USANA Earns Spot on 2026 USA TODAY Top Workplaces List
- Employee Culture Recognition: USANA Health Sciences has earned a spot on the 2026 USA TODAY Top Workplaces list, indicating its standout performance among 40,500 participating organizations and reflecting its commitment to a people-first culture and employee engagement.
- Benefits and Support: The company provides free onsite gym and healthcare amenities along with competitive health insurance plans, demonstrating its commitment to employee health and well-being, which enhances employee satisfaction and retention.
- Educational Support Policy: USANA also supports continuing education through tuition reimbursement, further enhancing employees' career development opportunities and improving the overall talent quality within the company.
- Feedback-Driven Recognition: The award is based on anonymous employee feedback collected through Energage surveys, emphasizing the credibility of the company's leadership and the alignment of employees with the corporate culture, thereby increasing the company's appeal to job seekers and customers.
See More
USANA Health Sciences Q1 2026 Earnings Call Insights
- Sales Growth Highlight: USANA's core nutritional business achieved net sales of $204 million in Q1 2026, reflecting a 7% sequential increase driven by active customer growth, particularly in the Chinese market, which strengthens the company's competitive foundation in the health product sector.
- Hiya Performance: Hiya generated $32 million in net sales in the first quarter with 186,000 active subscribers, and despite facing disruptions in the Meta advertising environment, management anticipates stronger performance in the second half of 2026, indicating its market potential and customer appeal.
- Rise Wellness Market Performance: Rise Wellness delivered $14 million in net sales for Q1, with growth primarily attributed to the national launch of Protein Pop Plus at Costco, showcasing effective retail execution strategies that support future sales growth for the company.
- Full-Year Outlook: USANA reaffirmed its full-year 2026 net sales guidance of $925 million to $1 billion, while projecting Hiya's sales between $140 million and $155 million, demonstrating the company's confidence in future growth and emphasis on technology modernization investments.
See More
USANA Health Sciences Q1 Earnings Exceed Expectations
- Earnings Beat: USANA Health Sciences reported a Q1 non-GAAP EPS of $0.61, exceeding expectations by $0.17, indicating a strong rebound in profitability that boosts investor confidence.
- Revenue Growth: The company achieved $250 million in revenue for Q1, a 0.2% year-over-year increase, surpassing market expectations by $9.01 million, demonstrating stable sales performance in a competitive market.
- Fiscal Year 2026 Outlook: USANA reiterated its fiscal year 2026 outlook, projecting core nutritional business net sales between $720 million and $765 million, reflecting confidence in future growth driven by product innovation and omnichannel strategies.
- Profitability Forecast: The company expects net earnings between $20 million and $27 million for FY 2026, with diluted EPS ranging from $1.11 to $1.45, and adjusted diluted EPS between $1.95 and $2.29, indicating ongoing improvements in profitability.
See More
The Power of Smiling in Leadership
- Impact of Smiling: Kevin Guest, CEO of USANA Health Sciences, emphasizes that smiling is not just superficial; it conveys care and trust, quickly reducing stress and improving interpersonal interactions, thereby enhancing workplace atmosphere.
- Essence of Leadership: Guest highlights through personal experiences and research that a smile can change people's responses, stressing the importance of caring for others and remembering names in one's career, as these small actions can have a profound impact.
- Importance of Relationships: He underscores that building strong relationships is central to both leadership and personal fulfillment, where clear goals and a strong 'why' can guide actions, fostering teamwork and execution.
- Charity and Social Responsibility: By selling his book,
See More
USANA Launches Glow™, Its First Skin Supplement
- Product Innovation: USANA has launched Glow™, a skincare supplement designed to support skin health at the cellular level, marking a strategic shift from traditional topical products to internal supplements, which is expected to attract consumers focused on inner beauty.
- Ingredient Advantage: Glow™ features clinically supported ingredients like Damasty®, along with astaxanthin from red algae and grape seed extract, aimed at enhancing skin moisture barriers and resisting environmental stress, thereby increasing the product's market competitiveness.
- Clinical Validation: Clinical trials involving 162 women aged 18 to 65 demonstrated significant improvements in skin appearance with Glow™, and consumer feedback indicates its effectiveness in enhancing skin radiance and even tone, further bolstering the brand's credibility.
- Market Outlook: As consumers increasingly prioritize internal skin health, the launch of Glow™ not only meets market demand but also opens new growth opportunities for USANA in the skincare sector, which is expected to drive future sales growth.
See More
USANA Launches Glow™, Its First Skin Supplement
- Product Innovation: USANA has launched Glow™, its first skin supplement designed to support skin health at the cellular level, marking a strategic shift from traditional topical solutions to internal supplements, catering to consumer demand for holistic beauty.
- Ingredient Advantage: Glow™ features clinically studied ingredients like Damasty®, along with rose extract and bioactive melon superoxide dismutase, which help enhance skin radiance and evenness while boosting the skin's resilience against environmental stressors, showcasing significant antioxidant effects.
- Clinically Proven Results: In clinical trials involving 162 women, Glow™ demonstrated a 26% increase in skin radiance after two months and a 40% increase after three months, with 100% of participants reporting improved skin radiance within two months, underscoring the product's efficacy.
- Market Potential: As consumers increasingly prioritize internal beauty, the introduction of Glow™ not only expands USANA's product line but also opens new growth opportunities in the competitive skincare market, expected to drive sales growth and enhance brand loyalty.
See More
